Cargando…
Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer
Cell transmembrane receptors and extracellular matrix components play a pivotal role in regulating cell activity and providing for the concerted integration of cells in the tissue structures. We have assessed DNA methylation in the promoter regions of eight integrin genes, two nidogen genes, and the...
Autores principales: | Strelnikov, Vladimir V., Kuznetsova, Ekaterina B., Tanas, Alexander S., Rudenko, Viktoria V., Kalinkin, Alexey I., Poddubskaya, Elena V., Kekeeva, Tatiana V., Chesnokova, Galina G., Trotsenko, Ivan D., Larin, Sergey S., Kutsev, Sergey I., Zaletaev, Dmitry V., Nemtsova, Marina V., Simonova, Olga A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838398/ https://www.ncbi.nlm.nih.gov/pubmed/33500458 http://dx.doi.org/10.1038/s41598-021-81851-y |
Ejemplares similares
-
Abnormal Hypermethylation of CpG Dinucleotides in Promoter Regions of Matrix Metalloproteinases Genes in Breast Cancer and its Relation to Epigenomic Subtypes and HER2 Overexpression
por: Simonova, Olga A., et al.
Publicado: (2020) -
Parental Origin of the RB1 Gene Mutations in Families with Low Penetrance Hereditary Retinoblastoma
por: Alekseeva, Ekaterina A., et al.
Publicado: (2021) -
Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing
por: Nemtsova, Marina V., et al.
Publicado: (2020) -
DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer
por: Sigin, Vladimir O., et al.
Publicado: (2023) -
DNA methylation markers panel can improve prediction of response to neoadjuvant chemotherapy in luminal B breast cancer
por: Sigin, Vladimir O., et al.
Publicado: (2020)